FDA Inspection 1056348 — Ignatius P. Godoy, M.D.

Ignatius P. Godoy, M.D. — FEI 3014133792

The FDA completed an inspection of Ignatius P. Godoy, M.D. on June 8, 2018 in Paramount, CA. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 2 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
June 8, 2018
Fiscal Year
2018
Product Type
Biologics
Project Area
Bioresearch Monitoring
Location
Paramount, CA (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
753021 CFR 312.62(b)Case history records- inadequate or inadequate
756021 CFR 312.60FD-1572, protocol compliance